Printer Friendly

Ultimate Bariatrics to Offer Newly FDA Approved Orbera Bariatric System in US.

M2 PHARMA-August 17, 2015-Ultimate Bariatrics to Offer Newly FDA Approved Orbera Bariatric System in US


The Orbera Managed Weight Loss System received its final approval on 5 August and Ultimate Bariatrics will be one of the first in the country to offer this new tool in helping people achieve their weight loss goals, the company said on Monday.

According to the company, the Orbera System, which combines a gastric balloon with nutritional coaching and exercise programs, is indicated for adult patients suffering from obesity with a BMI of 30 to 40 who desire a weight loss solution that does not require more invasive traditional surgery.

While new to the United States, the Orbera device has more than 220,000 balloons distributed in over 80 countries and approximately 230 published papers documenting its clinical results.

During clinical study, participants who used the Orbera balloon for its intended six-month period were able to lose, on average, three times as much bodyweight as participants who only adhered to a diet and exercise plan.

Orbera is easier to administer to patients, simply by being placed into the stomach through the mouth using a minimally invasive endoscopic procedure with mild sedation, and then inflated with saline solution to the size most suited to the patient's body structure.

Adam Smith D.O., FACOS has been chosen by Apollo Endosurgery, the makers of Orbera to be a spokesperson for the Orbera balloon, and participated in its clinical trials before FDA approval.

In his ongoing quest to stand up for the rights of the obese population, Smith was appointed as a spokesperson by the Obesity Action Coalition and Allergan as a part of the Voice My C.H.O.I.C.E. campaign, he served as the president of the American College of Osteopathic Surgeons in 2013, and is a member of many professional medical societies.

Smith's home practice, Ultimate Bariatrics (formerly known as Fort Worth LAP-BAND) has been providing for the bariatric health of the Fort Worth, Texas area for years.

((Comments on this story may be sent to

COPYRIGHT 2015 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Aug 17, 2015
Previous Article:Prima Biomed expects milestone payment for IMP701 LAG-3 programme.
Next Article:US Group Purchasing Organisation Amerinet Awards Teleflex New Agreement with for Surgical Instruments.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters